454PDFirst in human, a phase I study of ISU104, a novel ErbB3 monoclonal antibody, in patients with advanced solid tumoursS B Kim,B Keam,S Shin,Y S Chae,T M Kim,M S Kim, J G Kim,K Park, J S Ahn,L C Park,E Lee,J Juhn,S Kim,S B Hong,M J AhnAnnals of Oncology(2019)引用 3|浏览60暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要